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ABSTRACT
The inhibitor g-Strophantin, also known as ouabain, is a specific inhibitor of the Na+/K+-ATPase. In this 
work ouabain has been used for the inhibition of the Na+/K+-ATPase in human erythrocytes and isolated enzyme 
from pig kidney. Enzymatic activity of the Na+/K+-ATPase has been measured in a broad concentration range of 
ouabain in two different in vitro investigations. As a potent inhibitor of the sodium pump the cardiotonic steroid 
ouabain inhibits its enzymatic activity on both isolated human red blood cells and on the purified enzyme from 
pig kidney. Na+/K+-ATPase activity in erythrocyte can be determined by measuring the ouabain-sensitive uptake 
of 86Rb (as a congener for potassium). This work provides evidence that very low concentrations of ouabain in 
the nM range can stimulate increase of Na+/K+-ATPase activity in human erythrocytes, in contrast to inhibition 
of the purified enzyme from pig kidney, where such an effect was not observed.
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Introduction
Na+/K+-ATPase is a highly conserved, ubiquitous membrane protein (EC 3.6.1.37) 
and is a member of the P-type ATPase superfamily. The enzyme is composed of three 
sub-units: the α-subunit (≈113 kDa) binds ATP, sodium and potassium ions, contains the 
phosphorylation site and has an equal number of membrane spanning regions (ANTOLOVIĆ 
et al., 1991). The smaller beta sub-unit (≈35 kDa glycoprotein) is necessary for activity 
of the complex and its correct insertion in the plasma membrane of the animal cell. The 
gamma sub-unit (≈10 kDa) is the smallest sub-unit and its function in the Na+/K+-ATPase 
and is, until now, not well defined. Several isoforms of both alpha and beta sub-units have 
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been identified (KAPLAN, 2002). The Na+/K+-ATPase, or sodium pump, carries out the 
coupled extrusion and uptake of Na+ and K+ ions across the plasma membranes of cells 
of higher eukaryotes. Na+/K+-ATPase is specifically inhibited by cardiotonic steroids 
(SCHATZMANN, 1953) which bind to a specific conformation of Na+/K+-ATPase formed 
in the catalytic cycle during the hydrolysis of ATP (HANSEN, 1984; GLYNN et al., 1985). 
The Na+/K+-ATPase is the only known pharmacological receptor for cardiotonic steroids 
such as digitalis. Observations, including the tight conservation of the cardiac glycoside 
binding site over many phila, suggest that endogenous inhibitors of the Na+/K+-ATPase 
might exist in the mammalian body. Accumulated evidence published in the last decade 
suggests that several compounds of cardienolide or bufadienoide structure are present in 
humans and animals and have an influence on the physiological role of the Na+/K+-ATPase 
in the cell. For more than 200 years, digitalis, a cardiotonic steroid and its congeners have 
been used to treat congestive heart failure. Modern understanding of digitalis therapy 
arose 50 years ago, when in 1953 Schatzmann discovered that the cardiotonic steroids 
are specific inhibitors of the sodium pump and that the digitalis receptor is the Na+/K+-
ATPase of the plasma membranes. The discovery of the Na+/Ca2+ exchanger in the late 
1960s in mammalian cardiac muscle led to the view that inhibition of the sodium pump 
by cardiotonic steroids leads to an increase in the concentration of intracellular Ca2+ as 
secondary event, which in turn results in a positive inotropic effect on cardiac muscle. 
α
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 isoforms reside in plasma membrane areas close to the endoplasmic reticulum. Such 





isoforms of Na+/K+-ATPase in such a restricted area leads to an exchange in cytosolic 
Na+ and, indirectly, Ca2+ concentration. In turn, this modulates the Ca2+ content of the sar-
coplasmic reticulum and Ca2+ signaling and leads finally to the positive inotropic effect of 
cardiac glycosides and altered gene and expression of the proteins (SCHEINER-BOBIS and 
SCHONER, 2001). Additionally, it became evident that in contrast to previous assumptions, 
the sodium pump itself may act as a hormone receptor, transducing the signal or causing 
an interaction with the cardiotonic steroid. Ouabain-induced cross-talk in the cell involves 
highly complex signaling cascades which lead to the activation of transcription factors as 
NF-κB and AP-1 (AIZMAN et al., 2001). Changes in ouabain concentration in the blood 
stream will affect the contractility, growth rate and differentiation of a great number of 
the cells in the tissue in a specific way.
Materials and methods
86RbCl (Amersham Biosciences) with specific radioactivity of 1 mCi/mL Rb, and 
Silicon oil AR 200 and 20 (Wacker Chemie, Munich, Germany) were used. All other 
chemicals were of the highest available purity.
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Enzyme and assays. Na+/K+-ATPase in the range of 28-32 U·mg-1 protein was isolated 
from pig kidneys by a modification of Jørgensen’s procedure (JØRGENSEN, 1974). One 
enzyme unit (U) is defined as the amount of the enzyme catalyzing the hydrolysis of 1 µmol 
ATP at 37 °C under the conditions of the coupled spectrophotometric assay (SCHONER et 
al., 1967). Impurities from other ATPases were below 0.4%, as estimated by difference from 
a control with ouabain. Protein concentration was determined by the method of LOWRY et 
al. (1951) using Lab-Trol as a standard. Lab-Trol is a mixture of proteins and enzymes used 
for the calibration of assays in clinical chemical analysis. All buffers used were adjusted 
to their respective pH value at room temperature. 
+Rb uptake in human erythrocytes. The blood was taken by venipuncture in the pres-
ence of heparin as an anticoagulant. The cells were subsequently washed three times with 




, 1 mM MgSO
4
, 
Fig. 1. Structures of the known inhibitors of the sodium pump. Ouabain and digoxigenin both with 
the unsaturated five-membered lactone ring at the C17 position belong to the cardienolide class 
and 19-norbufagenin, and manrinobufagenin with unsaturated six-membered lactone ring on the 
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1.4 mM CaCl
2
, and 2.5 mM glucose, pH 7.4) and incubated with or without ouabain in 
the Krebs-Ringer buffer for 15 min. at 37 °C. 86Rb+ was added to a final concentration of 
2 µCi/mL, and the reaction was allowed to proceed for 15 min. at 37 °C. 86Rb+ uptake 
was terminated by washing thrice with ice-cold Krebs-Ringer buffer. The cells were then 
lysed with lysis buffer (50 mM NaOH, 1% Triton X-100) and incubated for 5 min. at room 
temperature. The radioactivity of the cell lysates was determined after adding scintillation 
mixture solution. Protein concentration per well was determined according to the Lowry 
assay and averaged. For this, cells contained in three wells were taken through the proce-
dure without the addition of a label.
Results 
Na+/K+-ATPase activity was influenced in the presence of ouabain. The ouabain-
specific inhibition of the sodium pump has been shown on the purified enzyme from pig 
kidney and on isolated human erythrocytes. The inhibition rate for ouabain of the Na+/
K+-ATPase purified from pig kidney was in the µmolar range, as shown in Table 1. This 
is in concordance with in the literature-published ouabain concentrations which exhibit 
half the maximal inhibition of the Na+/K+-ATPase. Low concentrations of the inhibitor in 
nanomolar range did not influence hydrolytic activity of the sodium pump tested in vitro 
assay, as reported in material and methods.
Fig. 2. Inactivation of isolated Na+/K+-ATPase from pig kidney by ouabain as a function of its 
concentration. Activity of the Na+/K+-ATPase measured by the Rubidium uptake in the human 
erythrocytes in the presence of different concentrations of ouabain. Values are normalized and 
compared to the Na+/K+-ATPase activity of the control erythrocytes incubated with 86Rb in 
absence of ouabain.
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In contrast to the enzymatic inhibition of the Na+/K+-ATPase of purified enzyme the 
Rubidium uptake into the human erythrocytes did show a difference in the Na+/K+-ATPase 
activity in the presence of the very low ouabain concentrations. Nanomolar concentrations 
of ouabain increased the activity of the Na+/K+-ATPase in human erythrocytes. Although 
the activity of the sodium pump in human erythrocytes increased at low ouabain concentra-
tions the IC
50 
for ouabain value was the same as the isolated enzyme from the pig kidney, 
as shown in Table 1.
Fig. 3. Inactivation of isolated Na+/K+-ATPase from pig kidney by ouabain as a function of its 
concentration. Purified Na+/K+-ATPase (60 µg) was incubated with different concentrations of 
ouabain for 30 min. at 37 °C in the presence of 3mM ATP, 3 mM MgCl
2 
and 150 mM NaCl.
Table 1.Various concentrations of ouabain yielding half maximal inhibition of Na+/K+-ATPase 
calculated with non linear regression in GraphPad Prism software.
Ouabain Na+/K+-ATPase from pig kidney Na+/K+-ATPase from human erythrocytes
IC
50
 1.37 × 10-8 M 4.34 × 10-8 M
Discussion
In certain cell types the signalling Na+/K+-ATPase and its protein partners are compart-
mentalized in coated pits (i.e., caveolae) on the plasma membrane. Caveolae are membrane 
microdomains that were first identified as flask-shaped vesicular invaginations of plasma 
membrane enriched in cholesterol, glycosphingolipids, and sphingomyelin (LIU et al., 2002; 
RAZANI et al., 2002). Binding of ouabain to the signalling Na+/K+-ATPase activates the 
cytoplasmic tyrosine kinase Src, resulting in the formation of an active “binary receptor” 
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that phosphorylates and assembles other proteins into different signalling modules. This 
in turn activates multiple protein kinase cascades including mitogen-activated protein 
kinases and protein kinase C isozymes in a cell-specific manner. Crosstalk among the 
activated pathways eventually results in changes in the expression of a number of genes 
(SCHONER, 2002). Although ouabain stimulates hypertrophic growth in cardiac myocytes 
and proliferation in smooth muscle cells, it also induces apoptosis in many malignant cells. 
Because the Na+/K+-ATPase has to interact with Src, EGFR, and other proteins to transmit 
the ouabain signal, it is possible that the signalling enzyme may have to be preassembled 
with its signalling partners in caveolae. Caveolins are 21-24 kDa membrane-associated 
scaffolding proteins, with multiple cellular functions that typify caveolae (LIU et al., 2002). 
Mammals express three different caveolin genes that encode five different protein isoforms, 
the expression and distribution of which are tissue-specific (RAZANI et al., 2002). Caveolins 
directly interact with cholesterol and many signalling proteins, including receptors, Src 
family kinases, and adapter proteins. Recent studies have indicated that many of these 
interactions are mediated through digoxin and ouabain, and vertebrate-derived aglycones 
such as bufalin and marinobufagenin. Although they have been considered for a long time 
only as drugs, there is now ample evidence to indicate that some of these compounds can 
function as steroid hormones (SCHONER, 2002; LAREDO et al., 1997).
Increased activity of the Na+/K+-ATPase in human erythrocytes in the presence of 
nM concentrations of cardiotonic steroid ouabain may suggest that the Na+/K+-ATPase in 
erythrocytes might be a part of the caveolin-similar structures which are activated by the 
steroid glycosides during which effect of insertion of additional Na+/K+-ATPase occurs 
in the plasma membrane. 
Conclusion
This work has produced evidence that ouabain as a potent inhibitor of the sodium pump 
has the same inhibition rate for the isolated Na+/K+-ATPase in the micromolare range and 
that in the red blood cells, respectively, but in the presence of the low nanomolar range 
ouabain increase the basal enzymatic activity of the Na+/K+-ATPase of isolated human 
erythrocytes in vitro.
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SAŽETAK
g-Strophantin koji je poznat i pod imenom ouabain je specifični inhibitor Na+/K+-ATPase. U ovom je radu 
ouabain korišten u inhibiciji enzimske aktivnosti Na+/K+-ATPase u čovječjim eritrocitima i izoliranom enzimu 
iz bubrega svinje. Kao jaki inhibitor natrijeve pumpe kardiotoni steroid, ouabain inhibira njenu aktivnost u oba 
slučaja u izoliranim čovječjim eritrocitima i pročišćenom enzimu. Aktivnost Na+/K+-ATPase u eritrocitima 
može biti proučavana koristeći se modelom aktivnog unosa radioaktivnog rubidija (86Rb) kao analoga kalija u 
samu stanicu. Ovaj rad prikazuje da vrlo niske nano-molarne koncentracije ouabaina mogu potaknuti povećanje 
enzimske aktivnosti Na+/K+-ATPase u čovječjim eritrocitima u usporedbi s izoliranim enzimom u kojeg taj 
učinak nije primijećen.
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